FDA Orange Book

Is there a generic for Onureg?

Onureg contains azacitidine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Onureg (azacitidine). The Orange Book shows its last listed patent expires June 3, 2030 and its last listed exclusivity ends September 1, 2027.

Run it in Rivvi

Map Onureg and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Onureg products in the Orange Book

Onureg products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
tablet, oral200MGMarketed (Rx)None0None
tablet, oral300MGMarketed (Rx)None0None

NDA 214120, held by BRISTOL MYERS SQUIBB CO. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Onureg patents

Patents listed for Onureg
PatentExpiresCoversUse codeNDA
12053482May 14, 2029Method of useU-2950214120
11571436May 14, 2029Drug productNone214120
8846628June 3, 2030Drug productU-2950214120

Onureg exclusivity

Exclusivity listed for Onureg
CodeMeaningExpiresNDA
ODE-320Orphan drug exclusivitySeptember 1, 2027214120

Onureg NDC codes

Questions

Is there a generic for Onureg?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Onureg (azacitidine). The Orange Book shows its last listed patent expires June 3, 2030 and its last listed exclusivity ends September 1, 2027.

What is the generic name for Onureg?

The active ingredient in Onureg is azacitidine, per the FDA Orange Book.

When does the Onureg patent expire?

The last patent listed for Onureg in the Orange Book expires June 3, 2030. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Onureg and Azacitidine

Try it on your own data today.

Free to start. Most teams are using it the same day.